Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CPT Code

CPT code 79445 – Intra-arterial radiopharmaceutical microsphere therapy


Code Definition

79445 is the CPT code for radiopharmaceutical therapy by intra-arterial particulate administration. In practice, it reports the delivery of yttrium-90 (Y-90) microspheres into the hepatic artery to treat liver tumors.

The code belongs to the authorized user who manages the radiation dose, and it is billed together with 37243 for the embolization. Catheter placement, mapping angiography, and dosimetry planning are each reported with their own codes.

Section
70010-79999 Radiology
Subsection
78012-79999 Nuclear Medicine
Code range
79005-79999 Therapeutic Nuclear Medicine
Code also known as
Y-90 radioembolization, Yttrium-90 microsphere therapy, hepatic radioembolization, SIRT (selective internal radiation therapy)
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CPT code 79445 reports the radiopharmaceutical part of Y-90 radioembolization, the intra-arterial delivery of the microspheres. It belongs to the authorized user who manages the radiation dose.

CPT 37243 is the main embolization code for Y-90 and is reported together with 79445, usually once per operative field. The NCCI practitioner tables carry no edit between the two codes.

An interventional radiologist reports 79445 only as the authorized user and sole treating physician. In a two-physician model, the delivery belongs to the authorized user’s service, and Sirtex lists 77778 for that model.

Selective catheterization (36245 to 36248) and a diagnostic hepatic angiogram (75726) are coded separately. Neither belongs inside 37243 or 79445.

Missing prior authorization, thin operative notes, a missing device code, and the wrong physician reporting 79445 drive most denials on Y-90 claims.

CPT code 79445: Official description and procedure overview

CPT code 79445 reports radiopharmaceutical therapy by intra-arterial particulate administration, which in practice means delivering yttrium-90 (Y-90) microspheres into the hepatic artery. It is reported alongside CPT 37243, the embolization code, by the physician who is the authorized user for the radioactive material. That split is spelled out in Radiology Today’s coding guidance for radioembolization.

The microspheres are either SIR-Spheres (resin, Sirtex Medical) or TheraSphere (glass, Boston Scientific). Both treat primary or metastatic liver tumors. The radioactive material must be handled by an authorized user under Nuclear Regulatory Commission rules. That rule decides who may report 79445 on the claim.

FieldDetail
Code79445
Official descriptorRadiopharmaceutical therapy, by intra-arterial particulate administration
Code typeNuclear medicine, therapeutic radiopharmaceutical
Clinical applicationY-90 microsphere delivery for hepatocellular carcinoma (HCC) or liver metastases
Reported withCPT 37243 for the embolization, plus selective catheterization and imaging codes
Who reports itThe authorized user: an interventional radiologist only when they are the authorized user and sole treating physician

The clinical procedure: Y-90 radioembolization step by step

Y-90 radioembolization usually runs over two sessions. The first is a mapping angiogram, and the second is the treatment day. Each code on the treatment-day claim needs its own support in the operative note.

  1. Vascular access: The interventional radiologist gains arterial access, usually femoral or radial, and advances a catheter toward the liver.
  2. Selective hepatic catheterization: The catheter is placed in the hepatic artery or a segmental branch under fluoroscopic guidance. This work is coded with 36245 to 36248, not with 37243.
  3. Dosimetry confirmation: The dose planned after the mapping session is confirmed before delivery. Document the prescribed dose and the dosimetry method.
  4. Microsphere delivery: The Y-90 microspheres are infused into the target vessel. The embolization is reported with 37243, and the radiopharmaceutical delivery with 79445 by the authorized user.
  5. Completion angiography: A final angiogram confirms stasis and rules out non-target embolization. Record that finding explicitly.

Payers return Y-90 claims most often when the note skips the access route, the target artery, the agent and dose, or confirmation of delivery. Each of those details supports a different code on the claim. A note that names every hepatic branch reached supports 36247, plus 36248 for each additional branch in the same vascular family.

What CPT code 79445 includes and excludes

CPT code 79445 covers the radiopharmaceutical administration only. Catheterization, the embolization itself, diagnostic angiography, and the microsphere device are reported with their own codes. Building a clean claim for a Y-90 treatment day means listing each of them correctly.

ServiceStatusCode to report
Intra-arterial microsphere delivery (authorized user)Covered by 7944579445 (79445-26 for the physician in a hospital or ASC)
Embolization of the tumor territory with Y-90Reported together with 79445; no NCCI edit pairs the two37243, usually once per operative field
Selective catheter placementSeparately reportable36245 to 36248, typically 36247 and 36248 for hepatic branches
Diagnostic hepatic angiographySeparately reportable only as a distinct diagnostic study75726-26, with modifier 59 when performed with 37243
Y-90 microsphere deviceSeparately reportableC2616 on Medicare hospital outpatient and ASC claims
Tc-99m MAA injection on the mapping dayPart of the nuclear medicine studyNever 79445

Sirtex adds one rule that catches coders out. A precautionary coil in the gastroduodenal or gastric artery on the treatment day is not billed as 37242. Only 37243 is reported.

How CPT 79445 and CPT 37243 work together

CPT 79445 and CPT 37243 are reported together for Y-90 radioembolization, because they describe two different parts of the same treatment. Code 37243 is the embolization, and 79445 is the radiopharmaceutical delivery by the authorized user.

AttributeCPT 79445CPT 37243
Official descriptorRadiopharmaceutical therapy, by intra-arterial particulate administrationVascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction
Code familyNuclear medicine, therapeuticSurgery, cardiovascular (transcatheter embolization)
What it describesAdministration of the radioactive microspheresEmbolization of the vessels feeding the tumor
Who reports itThe authorized userThe physician who performs the embolization, usually the interventional radiologist
Units on one dateOne administrationUsually one per operative field; a second unit for a separate field
Can both be billed on the same date?Yes. They are reported together, with no NCCI edit between them and no modifier needed to pair themYes. 37243 is the main embolization code for Y-90

Key rule: Report 37243 for the embolization on every Y-90 treatment, and add 79445 when the same physician is the authorized user. The CMS NCCI procedure-to-procedure tables for practitioners carry no edit between 37243 and 79445 in either direction. Pairing them is not a bundling error.

Two units of 37243 apply when separate operative fields are treated in one session, such as tumors in both liver lobes. Medicare does not accept modifier 50 on 37243, so the second unit takes XS, 76, or 59, as the payer instructs.

Who reports 79445: The authorized user

The Society of Interventional Radiology assigns 79445 to the authorized user. An interventional radiologist reports it only when they are the authorized user and the sole treating physician.

When a radiation oncologist is the authorized user, the delivery falls under that physician’s service and stays off the interventional radiologist’s claim. The Sirtex 2026 reimbursement guide lists 77778 for this two-physician model. Sirtex also flags a Medicare NCCI edit between 37243 and 77778, so check it before one provider reports both.

The diagram below maps each treatment-day code to the physician who reports it under both models.

Two-panel diagram of who reports which code on a Y-90 treatment day. One-physician model: the IR reports 36245 to 36248, 37243 ($482.31 physician, facility) and 79445 as authorized user ($106.21 as 79445-26). Two-physician model: the IR reports 36245 to 36248 and 37243, and the authorized user reports 77778 ($459.93 as 77778-26). Either model: C2616 with 37243 on facility claims, 75726-59 only for a distinct diagnostic study.
The IR keeps 37243 in both models, and the authorized user decides whether the delivery is billed as 79445 or 77778. Figures are CMS 2026 national rates as listed in the Sirtex 2026 hospital outpatient guide.

ICD-10 codes that support CPT code 79445

A Y-90 claim needs a liver malignancy diagnosis that matches the payer’s coverage policy. The codes below appear in Sirtex’s list of potential diagnoses for radioembolization. CrossCoder’s procedure-to-diagnosis crosswalk tool helps confirm the pairing before you submit.

ICD-10-CM codeDescriptionNote
C22.0Liver cell carcinomaThe usual primary diagnosis for HCC treatment
C78.7Secondary malignant neoplasm of liver and intrahepatic bile ductLiver metastases from another primary site
C18.0 to C18.9Malignant neoplasm of colonReported with C78.7 for colorectal liver metastases
C19Malignant neoplasm of rectosigmoid junctionReported with C78.7 when it is the primary site
C20Malignant neoplasm of rectumReported with C78.7 when it is the primary site

Use the most specific code the record supports. An unspecified liver code such as C22.9 invites a medical necessity denial when the pathology names the tumor type.

Documentation requirements for CPT code 79445

The note for a Y-90 treatment day must support every code on the claim, not only 79445. Payer auditors look for seven elements.

  • Catheter access and position: Name the access site and each vessel catheterized, so the 36245 to 36248 codes are supported.
  • Artery targeted: Name the hepatic branch or segment treated, such as the right hepatic artery, segment 6/7 branch.
  • Agent and dose: Name the product (SIR-Spheres or TheraSphere) and the activity delivered in GBq or mCi.
  • Embolization detail: Describe the embolization of each operative field, which supports 37243 and any second unit.
  • Confirmation of delivery: Record angiographic evidence that the agent reached the intended territory without non-target embolization.
  • Diagnosis: State the ICD-10-CM code and indication, such as C22.0 for HCC or C78.7 for liver metastases.
  • Authorized user attestation: The authorized user signs for the radiopharmaceutical delivery and the dosimetry it followed.

A diagnostic angiogram billed on the treatment day needs its own description of a diagnostic study. A note that only gives the catheter position will not support 75726. Check the Local Coverage Determination (LCD) for your MAC jurisdiction before billing.

Medicare and payer coverage for CPT code 79445

Medicare covers CPT code 79445 when the documentation supports an approved indication under the applicable LCD. Coverage is not nationally uniform, because each Medicare Administrative Contractor (MAC) maintains its own LCD.

Running insurance eligibility verification before the treatment session confirms active coverage. It also shows whether the plan adds its own criteria for Y-90.

Payer typeCovered indications (general)Prior auth required?
Medicare FFSHCC (C22.0), colorectal liver metastases (C78.7), and other hepatic indications per MAC LCDNot required for FFS Medicare; LCD documentation required
Medicare AdvantageFollows the Medicare LCD with plan-specific addendaMost plans require prior authorization
Commercial payersVaries by plan; some limit coverage to specific tumor typesPrior authorization required by most commercial plans
MedicaidState-specific; many states cover HCC, and metastatic indications varyMost state plans require prior authorization

Prior authorization: What payers require before approving 79445 claims

Most commercial payers and Medicare Advantage plans require prior authorization before the treatment session. Send these documents with the request:

  • Pre-procedure CT or MRI showing tumor extent and vascular anatomy
  • The oncology consultation note confirming the indication
  • The mapping angiogram report and the dosimetry calculation
  • Performance status documentation

Turnaround usually runs 5 to 14 business days, and urgent requests may be expedited. A pending or denied authorization on the treatment date is hard to fix after the service. Request it well ahead of the scheduled date.

Routing claims through a clearinghouse such as the Claim.MD clearinghouse adds payer edit feedback before submission. A missing authorization number then comes back as an edit your team can fix before the payer sees the claim.

2026 Medicare reimbursement for CPT code 79445

Medicare pays CPT code 79445 differently by setting and by who bills. The figures below are CMS 2026 national rates before geographic adjustment, as Sirtex lists them. Physician and hospital outpatient rows come from the Sirtex 2026 hospital outpatient guide. Office-based lab rows come from the Sirtex 2026 office-based lab guide.

Confirm your local rate in the CMS Physician Fee Schedule lookup tool or the FastRVU RVU lookup.

Billing lineSetting2026 national average (Sirtex)
79445-26Physician, hospital or ASC (1 doctor model)3.18 RVUs, $106.21
79445Hospital outpatient (OPPS, APC 5661)$238.39
79445 (global)Office-based labContractor priced (Sirtex OBL guide)
37243Physician, hospital or ASC14.44 RVUs, $482.31
37243Office-based lab239.37 RVUs, $7,995.17 (Sirtex OBL guide)
77778-26Physician, two-physician model with a separate authorized user13.77 RVUs, $459.93

Important: The microsphere device is not paid inside 79445. On Medicare hospital outpatient and ASC claims, report it with HCPCS C2616. Sirtex notes that 37243 is device-intensive in the facility setting and is denied without the device code.

Pro Tip

In a hospital outpatient setting, the hospital reports 79445 under OPPS and the physician reports 79445-26. Confirm which entity bills which line before the claim goes out. A global 79445 from the physician while the hospital also reports it invites an overpayment demand.

Modifiers for CPT code 79445

Modifiers on a Y-90 claim decide which entity is paid for which part of the service. They also show when a second embolization or a diagnostic angiogram is distinct. Check current edit guidance in the AAPC Codify CPT lookup.

ModifierUse caseNotes
26Physician reporting the professional component of 79445 in a hospital or ASCThe facility reports its own line; in an office-based lab the physician bills the global code
XS, 76, or 59Second unit of 37243 for a separate operative field in the same sessionFollow the payer’s preference; Medicare does not accept modifier 50 on 37243
59Diagnostic angiogram (75726) performed with 37243Only when a distinct diagnostic study is documented
NonePairing 37243 with 79445No NCCI edit pairs the two codes, so no modifier is needed
RT / LTRight or left lobe treatmentPayer-specific and not universally required

Common denial reasons for CPT code 79445 and how to fix them

CPT code 79445 denials cluster around a handful of root causes. The CARC code on the remittance shows which one applies. A systematic denial management workflow turns each failure into a process fix. The CARC denial codes tell you why the payer rejected the claim.

Denial reasonCorrective action
Missing prior authorizationStart the authorization request at scheduling, not at billing. Send imaging, oncology notes, and dosimetry with it. Appeal with medical necessity documentation if the service was urgent.
Diagnosis not covered under the payer’s LCD or policyUse the most specific ICD-10-CM code, such as C22.0 for HCC rather than C22.9. Attach a letter of medical necessity from the treating oncologist.
Insufficient documentation in the operative noteUse the seven-element checklist above. Add a template to the procedure note and audit a sample of notes before billing closes.
79445 reported by a physician who is not the authorized userMove the delivery to the authorized user’s claim. In the two-physician model, Sirtex lists 77778 for that work.
Second 37243 unit denied as a duplicateDocument the separate operative field and append XS, 76, or 59, as the payer instructs. Never use modifier 50 on Medicare claims.
Device code missing on a facility claimReport C2616 with 37243 on Medicare hospital outpatient and ASC claims.
Wrong component for the settingIn a hospital or ASC, the physician bills 79445-26. In an office-based lab, the physician bills the global code.

Pro Tip

Run a quarterly denial analysis on 79445 claims and sort by CARC code. If CARC 50 (medical necessity) accounts for more than 20% of denials, the problem sits in documentation or diagnosis specificity. Fix the clinical note template before fixing the claim form.

Before you submit: A Y-90 treatment-day claim checklist

A Y-90 claim has more moving parts than most code families. Check these five points before the claim leaves the practice:

  1. Charge capture: List 37243, 79445 for the authorized user, the catheterization codes, any diagnostic angiogram, and the device code.
  2. Physician roles: Confirm who the authorized user is. Put 79445 on that physician’s claim, or the two-physician code where that model applies.
  3. Units and modifiers: Count the operative fields embolized. Add a second 37243 unit with XS, 76, or 59 only for a separate field.
  4. Prior authorization: Log the reference number, approval date, and authorized dates of service against the encounter.
  5. Setting: Match the component to the place of service, with 79445-26 in a hospital or ASC and the global code in an office-based lab.

How Pabau keeps Y-90 radioembolization claims clean

On a Y-90 case, the billing team often rebuilds the claim from the operative note days later. A missing authorization number or patient detail only surfaces when the payer rejects the claim.

Pabau, a practice management platform, gives your team claims software for coders that checks each claim for missing or invalid details before it is sent. It tracks prior authorizations against the encounter and submits claims electronically through the Claim.MD clearinghouse.

The result is fewer returned claims on a high-value procedure, where a single denial can mean significant delayed revenue. Your coders still choose the codes, and Pabau flags missing or invalid details before the payer does.

Send cleaner Y-90 claims the first time

Pabau checks claims for missing or invalid details, tracks prior authorizations, and sends claims electronically through the Claim.MD clearinghouse. Your team spends less time reworking radioembolization denials.

Pabau billing workflow dashboard

Conclusion

Treat a Y-90 treatment day as one claim with two physician roles. Report 37243 for the embolization every time. Add 79445 only on the authorized user’s claim, and code the catheter work and any diagnostic angiogram separately.

Coders who drop 37243, or hold it back for a missing modifier, leave the main embolization payment unbilled. Fix the role assignment and the documentation once, and the rest of the claim follows. Book a demo to see how Pabau validates and submits radioembolization claims for your practice.

Continue your research

Continue your research

Need a framework for managing clearinghouse claim edits? Understanding how a medical billing clearinghouse works explains how payer edits, eligibility checks, and ERA routing reduce denials before they reach your AR queue.

Struggling with claim denial patterns across your code set? Revenue cycle management fundamentals covers how to build a denial prevention loop from charge capture through posting.

Want to understand what a superbill needs to include for IR procedures? Building a compliant medical superbill walks through the fields a compliant superbill carries.

Planning authorization before a Y-90 treatment date? The prior authorization process sets out each step from request to approval, so the treatment date is not left waiting on a payer.

Frequently asked questions

What does CPT code 79445 cover?

CPT code 79445 covers radiopharmaceutical therapy by intra-arterial particulate administration, such as Y-90 microsphere delivery to liver tumors. The authorized user reports it. The embolization (37243), catheter placement (36245 to 36248), and the microsphere device are reported with their own codes.

What is the difference between CPT 79445 and CPT 37243?

CPT 37243 reports the embolization of the tumor’s blood supply, and 79445 reports the radiopharmaceutical delivery by the authorized user. For Y-90 radioembolization, the two are reported together. No NCCI edit pairs them, so no modifier is needed to bill both on the same date.

Who reports CPT 79445, the interventional radiologist or the radiation oncologist?

The authorized user reports CPT 79445. An interventional radiologist reports it only when they are the authorized user and the sole treating physician. When a radiation oncologist is the authorized user, the delivery falls under that physician’s service, and Sirtex lists 77778 for this two-physician model.

Does Medicare cover CPT code 79445?

Yes, Medicare covers CPT code 79445 for approved indications under the patient’s MAC Local Coverage Determination. The most common are hepatocellular carcinoma (C22.0) and colorectal liver metastases (C78.7). Criteria vary by MAC jurisdiction, so confirm the applicable LCD before billing.

Is prior authorization required for CPT code 79445?

Prior authorization is required by most commercial payers and Medicare Advantage plans, but generally not by traditional Medicare fee-for-service. Send imaging, oncology notes, dosimetry, and performance status with the request. Allow 5 to 14 business days, and request it well before the treatment date.

What documentation is required to support a CPT code 79445 claim?

The note needs the access site and each vessel catheterized, the artery treated, the agent and dose, and the embolization of each operative field. It also needs confirmation of delivery, the ICD-10-CM diagnosis, a dosimetry reference, and the authorized user’s attestation. Missing any one invites a documentation denial.

What are the most common denial reasons for CPT code 79445?

The most common are a missing prior authorization, a diagnosis outside the payer’s policy, and a thin operative note. Others include 79445 billed by a physician who is not the authorized user, a missing device code, and the wrong component for the setting. The CARC code on the remittance shows which applies.

Avatar photo
Maja Popovska
Content Writer

Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.
×